Business

GNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors

GNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors.

articleGncc Capital, Inc.October 16, 20195/company/gncc-capital-inc/news/gncc-capital-inc-completion-of-pending-transaction-and-the-first-public-engagement-by-the-companys-new-board-of-directors
GNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors

About this update from Gncc Capital, Inc.

[{"type":"text","content":"\n\n\n\nGNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors\nPR Newswire\nLAS VEGAS, Oct. 16, 2019\n\n\n\nLAS VEGAS, Oct. 16, 2019 /PRNewswire/ -- GNCC Capital, Inc. (OTC: GNCP) (\"The Company\" or \"GNCC\") confirms that the related party transaction referred to October 10, 2019 has been ratified.\nYour recently appointed GNCC Directors confirm that at this time, GNCC will focus its activities in South Africa through its 40% shareholding in Jengu Pharma (Pty) Limited (\"Jengu\"). Jengu through its ownership of a South African Company which is presently growing Cannabis and primarily for export. Harvesting of this crop commences from mid-November to early December. It is recorded that the balance of the shares in Jengu are held directly by both Ms. Allen and Mr. Cox.\nYour Company's President, Ms. Nell-Mari \"Nella\" Allen holds a License in the Republic of South Africa for the cultivation of Cannabis and the manufacturing of pharmaceutical Cannabis related products for medical and research purposes. This License also permits the export of Cannabis from South Africa.\nAs previously stated, both of your Executive Directors have recognized the need to; and have committed to expend time in shareholder engagement. This ensures that all shareholders and investors become familiar with the Company's new business operations, opportunities, Licensing and the Cannabis Industry in South Africa; and more importantly, with their new Board of Directors.\nWe have had an extended period of time to familiarize ourselves with shareholder concerns and we recognize that we cannot \"rewrite the Company's history\". What we will do, is to bring our experience and our skills to drive our Company onwards and upwards. Our primary and overriding interest is that our shareholders share and embrace our passion and unwavering commitment to the unique opp...

More updates from Gncc Capital, Inc.